<DOC>
	<DOCNO>NCT03063112</DOCNO>
	<brief_summary>The study compare efficacy , safety impact quality life radiofrequency thermocoagulation chemical neurolysis bilateral thoracic splanchnic nerve management refractory pain develop patient suffer upper abdominal cancer .</brief_summary>
	<brief_title>Radiofrequency Chemical Neurolysis Thoracic Splanchnic Nerve Abdominal Cancer Pain</brief_title>
	<detailed_description>Radiofrequency thermocoagulation splanchnic nerve do bilaterally level thoracic vertebra T10 T11 ( enough study do test efficacy , safety impact quality life radiofrequency thermocoagulation splanchnic nerve level T10 ) . Aim Study compare efficacy , safety impact quality life radiofrequency thermocoagulation bilateral thoracic splanchnic nerve level T10 T11 vertebra chemical neurolytic block level T11 vertebra management upper abdominal cancer pain .</detailed_description>
	<mesh_term>Abdominal Neoplasms</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>1 . Patients suffer upper abdominal cancer pain . 2 . Visceral pain visual analogue pain score â‰¥ 4 . 3 . Normal coagulation profile . 4 . Positive diagnostic test . 5 . Written informed consent patient . 1 . Patients organ failure . 2 . Coagulation disorder . 3 . Local infection puncture site sepsis . 4 . Allergy contrast dye alcohol . 5 . Severe displacement intraabdominal structure . 6 . Pregnant woman . 7 . Documented metastatic lesion . 8 . Psychiatric illness affect cooperation . 9 . Decompensated cardiac disorder . 10 . Liver renal dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>